Criterium Energy has appointed Ben Arnott as a non-independent director and strategic advisor and announced details for its 2026 Annual General Meeting...
Pearson said underlying sales rose 4% in Q1 2026, supported by strong Virtual Learning growth, and confirmed it remains on track to meet full-year guidance...
Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and..
Fidelity European Trust highlighted its long-term focus on attractively valued companies with strong cash generation and dividend growth potential, as TotalEnergies and Deutsche Boerse contributed positively in March...
Fidelity Asian Values reported an 18.1% NAV gain for the year to 31 March 2026, with share price rising 23.5%, supported by stock selection and exposure to value opportunities across..
The company has completed its purchase of EPIC Guernsey, funding the deal through new share issuance and increasing total share capital to approximately 114.9 million shares pending AIM admission...
Planned study updates will reassess costs, pricing, and phased development options while supporting financing discussions and long-term downstream graphite ambitions...
Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update...
Assessment providers are adapting to candidates’ real-world pressures, creating both operational challenges and strategic opportunities for investors...
Fidelity Emerging Markets Limited reported a 58.8% NAV rise over 12 months to March 2026, outperforming its reference index, supported by strong stock selection in Taiwan and information technology...
Fidelity China Special Situations reported a 10.7% NAV increase over the 12 months to 31 March 2026, outperforming its benchmark amid renewed optimism around China’s innovation-led growth...
Criterium Energy has appointed Ben Arnott as a non-independent director and strategic advisor and announced details for its 2026 Annual General Meeting...
Pearson said underlying sales rose 4% in Q1 2026, supported by strong Virtual Learning growth, and confirmed it remains on track to meet full-year guidance...
Genflow Biosciences’ 2025 results highlight strong operational progress, including a major milestone in its dog aging study, advancement of its MASH program toward clinical readiness, expanded global patent protection, and new partnerships supporting future development...
Fidelity European Trust highlighted its long-term focus on attractively valued companies with strong cash generation and dividend growth potential, as TotalEnergies and Deutsche Boerse contributed positively in March...
Fidelity Asian Values reported an 18.1% NAV gain for the year to 31 March 2026, with share price rising 23.5%, supported by stock selection and exposure to value opportunities across Asian small caps...
The company has completed its purchase of EPIC Guernsey, funding the deal through new share issuance and increasing total share capital to approximately 114.9 million shares pending AIM admission...
Planned study updates will reassess costs, pricing, and phased development options while supporting financing discussions and long-term downstream graphite ambitions...
Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update...
Assessment providers are adapting to candidates’ real-world pressures, creating both operational challenges and strategic opportunities for investors...
Fidelity Emerging Markets Limited reported a 58.8% NAV rise over 12 months to March 2026, outperforming its reference index, supported by strong stock selection in Taiwan and information technology...
Fidelity China Special Situations reported a 10.7% NAV increase over the 12 months to 31 March 2026, outperforming its benchmark amid renewed optimism around China’s innovation-led growth...
